KDA|
|
IMAGE VIEW
Volume 46(4); July 2022
-
New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins
Kyuho Kim, Henry N. Ginsberg, Sung Hee Choi
Diabetes Metab J. 2022;46(4):517-532.
ReviewJuly 27, 2022
-
Endoplasmic Reticulum Stress and Dysregulated Autophagy in Human Pancreatic Beta Cells
Seoil Moon, Hye Seung Jung
Diabetes Metab J. 2022;46(4):533-542.
ReviewJuly 27, 2022
-
Renoprotective Mechanism of Sodium-Glucose Cotransporter 2 Inhibitors: Focusing on Renal Hemodynamics
Nam Hoon Kim, Nan Hee Kim
Diabetes Metab J. 2022;46(4):543-551.
ReviewJuly 27, 2022
-
Current Trends of Big Data Research Using the Korean National Health Information Database
Mee Kyoung Kim, Kyungdo Han, Seung-Hwan Lee
Diabetes Metab J. 2022;46(4):552-563.
ReviewJuly 27, 2022
- Beyond Liver Disease: Non-Alcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Kidney Disease Eugene Han Diabetes Metab J. 2022;46(4):564-566. EditorialJuly 27, 2022
- Comparative Effects of Sodium-Glucose Cotransporter 2 Inhibitor and Thiazolidinedione Treatment on Risk of Stroke among Patients with Type 2 Diabetes Mellitus Seung Eun Lee, Hyewon Nam, Han Seok Choi, Hoseob Kim, Dae-Sung Kyoung, et al. Diabetes Metab J. 2022;46(4):567-577. Original ArticleFebruary 8, 2022
- Reproductive Life Span and Severe Hypoglycemia Risk in Postmenopausal Women with Type 2 Diabetes Mellitus Soyeon Kang, Yong-Moon Park, Dong Jin Kwon, Youn-Jee Chung, Jeong Namkung, et al. Diabetes Metab J. 2022;46(4):578-591. Original ArticleJanuary 24, 2022
- Effect of Low-Dose Persistent Organic Pollutants on Mitochondrial Function: Human and in Vitro Evidence Se-A Kim, Hoyul Lee, Sung-Mi Park, Mi-Jin Kim, Yu-Mi Lee, et al. Diabetes Metab J. 2022;46(4):592-604. Original ArticleJanuary 26, 2022
- Effect of Different Types of Diagnostic Criteria for Gestational Diabetes Mellitus on Adverse Neonatal Outcomes: A Systematic Review, Meta-Analysis, and Meta-Regression Fahimeh Ramezani Tehrani, Marzieh Saei Ghare Naz, Razieh Bidhendi-Yarandi, Samira Behboudi-Gandevani Diabetes Metab J. 2022;46(4):605-619. Original ArticleMarch 8, 2022
- Prevalence of Diabetic Retinopathy in Undiagnosed Diabetic Patients: A Nationwide Population-Based Study Han Na Jang, Min Kyong Moon, Bo Kyung Koo Diabetes Metab J. 2022;46(4):620-629. Original ArticleFebruary 23, 2022
-
ReviewJul 27, 2022
New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins
Kyuho Kim, Henry N. Ginsberg, Sung Hee Choi
Diabetes Metab J. 2022;46(4):517-532.
-
ReviewJul 27, 2022
Endoplasmic Reticulum Stress and Dysregulated Autophagy in Human Pancreatic Beta Cells
Seoil Moon, Hye Seung Jung
Diabetes Metab J. 2022;46(4):533-542.
-
ReviewJul 27, 2022
Renoprotective Mechanism of Sodium-Glucose Cotransporter 2 Inhibitors: Focusing on Renal Hemodynamics
Nam Hoon Kim, Nan Hee Kim
Diabetes Metab J. 2022;46(4):543-551.
-
ReviewJul 27, 2022
Current Trends of Big Data Research Using the Korean National Health Information Database
Mee Kyoung Kim, Kyungdo Han, Seung-Hwan Lee
Diabetes Metab J. 2022;46(4):552-563.
- EditorialJul 27, 2022 Beyond Liver Disease: Non-Alcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Kidney Disease Eugene Han Diabetes Metab J. 2022;46(4):564-566.
- Original ArticleFeb 8, 2022 Comparative Effects of Sodium-Glucose Cotransporter 2 Inhibitor and Thiazolidinedione Treatment on Risk of Stroke among Patients with Type 2 Diabetes Mellitus Seung Eun Lee, Hyewon Nam, Han Seok Choi, et al. Diabetes Metab J. 2022;46(4):567-577.
- Ahead-of print
-
- Type 2 Diabetes Mellitus and Sarcopenia as Comorbid Chronic Diseases in Older Adults: Established and Emerging Treatments and Therapies
- Effects of Exercise Training and Chlorogenic Acid Supplementation on Hepatic Lipid Metabolism in Pre-Diabetes Mice
- Pharmacological and Nonpharmacological Treatments for Painful Diabetic Peripheral Neuropathy
- Glucolipotoxicity Suppressed Autophagy and Insulin Contents in Human Islets, and Attenuation of PERK Activity Enhanced Them in an ATG7-Dependent Manner
Special thematic issues
Best paper of the year
-
Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study Kyoung Jin Kim, Jimi Choi, Jae Hyun Bae, et al.
-
Ipragliflozin, an SGLT2 Inhibitor, Ameliorates High-Fat Diet-Induced Metabolic Changes by Upregulating Energy Expenditure through Activation of the AMPK/ SIRT1 Pathway Ji-Yeon Lee, Minyoung Lee, Ji Young Lee, et al.
-
Magnetic Resonance-Based Assessments Better Capture Pathophysiologic Profiles and Progression in Nonalcoholic Fatty Liver Disease Seung Joon Choi, Seong Min Kim, Yun Soo Kim, et al.
-
Effect of Sarcopenia and Body Shape on Cardiovascular Disease According to Obesity Phenotypes Hyun-Woong Cho, Wankyo Chung, Shinje Moon, et al.
v.47(3) 5 2023
v.47(2) 3 2023
v.47(1) 1 2023
v.46(6) 11 2022
v.46(5) 9 2022
v.46(4) 7 2022
v.46(3) 5 2022
v.46(2) 3 2022
v.46(1) 1 2022
v.45(6) 11 2021
v.45(5) 9 2021
